Correlation Between Erasca and ABVC Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Erasca and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Erasca and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Erasca Inc and ABVC Biopharma, you can compare the effects of market volatilities on Erasca and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Erasca with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Erasca and ABVC Biopharma.

Diversification Opportunities for Erasca and ABVC Biopharma

ErascaABVCDiversified AwayErascaABVCDiversified Away100%
-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between Erasca and ABVC is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Erasca Inc and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Erasca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Erasca Inc are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Erasca i.e., Erasca and ABVC Biopharma go up and down completely randomly.

Pair Corralation between Erasca and ABVC Biopharma

Given the investment horizon of 90 days Erasca Inc is expected to generate 0.58 times more return on investment than ABVC Biopharma. However, Erasca Inc is 1.74 times less risky than ABVC Biopharma. It trades about -0.01 of its potential returns per unit of risk. ABVC Biopharma is currently generating about -0.02 per unit of risk. If you would invest  278.00  in Erasca Inc on December 12, 2024 and sell it today you would lose (126.50) from holding Erasca Inc or give up 45.5% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Erasca Inc  vs.  ABVC Biopharma

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -60-40-200204060
JavaScript chart by amCharts 3.21.15ERAS ABVC
       Timeline  
Erasca Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Erasca Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar1.522.53
ABVC Biopharma 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ABVC Biopharma are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, ABVC Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar0.40.50.60.70.8

Erasca and ABVC Biopharma Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-7.83-5.87-3.9-1.93-0.02521.442.954.475.987.5 0.0100.0120.0140.0160.0180.0200.022
JavaScript chart by amCharts 3.21.15ERAS ABVC
       Returns  

Pair Trading with Erasca and ABVC Biopharma

The main advantage of trading using opposite Erasca and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Erasca position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.
The idea behind Erasca Inc and ABVC Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Global Correlations
Find global opportunities by holding instruments from different markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements